Dr. Saurabh Sharma is a pioneering researcher in nanoparticle-based therapies for metastatic cancer. His Ph.D. at BITS-PILANI, India, focused on nano-drug engineering, synthesizing targeted microRNA, siRNA, and chemotherapeutic nanoparticles for various tumors. At the Terasaki Institute for Biomedical Innovation, under Prof. Ali Khademhosseini and Prof. Eggehard Holler, he developed strategies to transport immunotherapeutic molecules across the blood-brain barrier for brain cancer treatment. Now a postdoctoral researcher at Stanford University's School of Medicine, guided by Dr. Amanda Kirane, he continues his groundbreaking work in cancer-targeted nanotechnology, with a focus on melanoma brain metastases. Specializing in immunotherapy, gene therapy, and chemotherapy, he designs innovative nanomedicines for preclinical and clinical use, advancing nanodrug manufacturing and delivery to metastatic sites and immune cells. Leading a multidisciplinary team, Dr. Sharma spearheads efforts to develop transformative nano-immunotherapy concepts. His leadership and expertise position him as the principal investigator for grants, fellowships, and seed awards, driving the development of novel therapies for metastatic cancer.
Stanford University School of Medicine
Stanford, California, USA
Surgical Oncology